Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-010636·Amphastar Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amphastar Pharmaceuticals Inc
Common Stock · CUSIP: 03209R103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Jack Y. Zhang
Shares: 12,524,153.00 · Class: 24.8%
- Mary Z. Luo
Shares: 12,524,153.00 · Class: 24.8%
- Applied Physics & Chemistry Laboratories, Inc.
Shares: 6,827,679.00 · Class: 14.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-010636
- Form type
- SCHEDULE 13G/A
- Filer
- Amphastar Pharmaceuticals, Inc.
- CIK
- CIK 1297184
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership